Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CDLX Cardlytics > Key Indicators
CDLX Cardlytics
9.550
-0.210-2.15%
Post Mkt Price
9.5500.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Receivable Turnover(T)
-12.02% 3.6018 12.06% 3.2795 20.9% 2.7776 20.9% 2.7776
Fixed Assets Turnover(T)
46.05% 13.6514 55.8% 12.7847 20.67% 11.589 20.67% 11.589
Total Asset Rate(T)
-19.24% 0.2569 -21.04% 0.25 -45.18% 0.3168 -45.18% 0.3168
ROIC
-2.62% -16.591% 41.77% -6.499% 11.73% -18.928% 11.73% -18.928%
ROE
-4.8% -23.404% 35.87% -9.699% 17.8% -30.326% 17.8% -30.326%
ROA
3.3% -12.885% 42.33% -6.267% 11.02% -15.248% 11.02% -15.248%
Efficiency Ratios
ROA 5 Year Average
-- -- -- -- 40.6% -22.063% -- --
Profitability Ratios TTM
Gross Margin
4.75% 38.165% 13.73% 39.055% 14.27% 38.687% 14.27% 38.687%
Operating Margin
-45.45% -42.593% -39.86% -41.058% -25.67% -36.259% -25.67% -36.259%
Net Margin
-19.73% -50.145% 26.97% -25.063% -62.3% -48.131% -62.3% -48.131%
EBITDA Margin
-23.26% -0.3547% 64.32% -0.0883% -50.83% -0.3291% -50.83% -0.3291%
R & D Expense Ratio
48.19% 16.360% 53.42% 15.680% 52.03% 14.260% 52.03% 14.260%
Sales Expense Ratio
4.99% 25.260% 2.33% 25.000% 1.94% 24.710% 1.94% 24.710%
Administration Expense Rate
11.66% 26.330% 7.22% 26.430% -0.44% 24.790% -0.44% 24.790%
Financial Health Ratios
Long-Term Debt to Equity Ratio
56.58% 41.069% 29.95% 32.349% -76.27% 27.682% -76.27% 27.682%
Total Assets to Common Equity
11.91% 193.121% 25.96% 172.999% -31.93% 182.973% -31.93% 182.973%
Debt to Asset Ratio
55.69% 42.149% 29.66% 33.227% -76.14% 28.555% -76.14% 28.555%
Current Ratio
-30.13% 0.8992 -83.04% 1.2944 -76.9% 1.0958 -76.9% 1.0958
Quick Ratio
-31.03% 0.866 -83.33% 1.2583 -77.08% 1.0712 -77.08% 1.0712
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- 64.82% 21.026% -- --
Revenue CAGR(5Y)
-- -- -- -- -2.06% 18.813% -- --
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
CEO: Ms. Lynne M. Laube
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...